Changes in the expression of drug-metabolising enzymes and drug transporters in mice with collagen antibody-induced arthritis

References

• Adlan AM, Panoulas VF, Smith JP, Fisher JP, Kitas GD. 2015. Association between corrected QT interval and inflammatory cytokines in rheumatoid arthritis. J Rheumatol. 42(3):421–428.
   PubMed Web of Science ®Google Scholar
• Aitken AE, Morgan ET. 2007. Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes. Drug Metab Dispos. 35(9):1687–1693.
   PubMed Web of Science ®Google Scholar
• Bi Y-A, Lin J, Mathialagan S, Tylaska L, Callegari E, Rodrigues AD, Varma MVS. 2018. Role of hepatic organic anion transporter 2 in the pharmacokinetics of R- and S-warfarin: in vitro studies and mechanistic evaluation. Mol Pharm. 15(3):1284–1295.
   PubMedGoogle Scholar
• Bi Y-A, Mathialagan S, Tylaska L, Fu M, Keefer J, Vildhede A, Costales C, Rodrigues AD, Varma MVS. 2018. Organic anion transporter 2 mediates hepatic uptake of tolbutamide, a CYP2C9 probe drug. J Pharmacol Exp Ther. 364(3):390–398.
   PubMed Web of Science ®Google Scholar
• Chung S-J, Kwon Y-J, Park M-C, Park Y-B, Lee S-K. 2011. The correlation between increased serum concentrations of interleukin-6 family cytokines and disease activity in rheumatoid arthritis patients. Yonsei Med J. 52(1):113–120.
   PubMed Web of Science ®Google Scholar
• Coutant DE, Hall SD. 2018. Disease-drug interactions in inflammatory states via effects on CYP-mediated drug clearance. J Clin Pharmacol. 58(7):849–863.
   PubMed Web of Science ®Google Scholar
• Cropp CD, Komori T, Shima JE, Urban TJ, Yee SW, More SS, Giacomini KM. 2008. Organic anion transporter 2 (SLC22A7) is a facilitative transporter of cGMP. Mol Pharmacol. 73(4):1151–1158.
   PubMed Web of Science ®Google Scholar
• Diao L, Li N, Brayman TG, Hotz KJ, Lai Y. 2010. Regulation of MRP2/ABCC2 and BSEP/ABCB11 expression in sandwich cultured human and rat hepatocytes exposed to inflammatory cytokines TNF-{alpha}, IL-6, and IL-1{beta}. J Biol Chem. 285(41):31185–31192.
   PubMed Web of Science ®Google Scholar
• Dickmann LJ, McBride HJ, Patel SK, Miner K, Wienkers LC, Slatter JG. 2012. Murine collagen antibody induced arthritis (CAIA) and primary mouse hepatocyte culture as models to study cytochrome P450 suppression. Biochem Pharmacol. 83(12):1682–1689.
   PubMed Web of Science ®Google Scholar
• He Y, Yang T, Du Y, Qin L, Ma F, Wu Z, Ling H, Yang L, Wang Z, Zhou Q, et al. 2020. High fat diet significantly changed the global gene expression profile involved in hepatic drug metabolism and pharmacokinetic system in mice. Nutr Metab (Lond)). 17:37.
   PubMed Web of Science ®Google Scholar
• Hisaeda K, Inokuchi A, Nakamura T, Iwamoto Y, Kohno K, Kuwano M, Uchiumi T. 2004. Interleukin-1beta represses MRP2 gene expression through inactivation of interferon regulatory factor 3 in HepG2 cells. Hepatology. 39(6):1574–1582.
   PubMed Web of Science ®Google Scholar
• Kawase A, Norikane S, Okada A, Adachi M, Kato Y, Iwaki M. 2014. Distinct alterations in ATP-binding cassette transporter expression in liver, kidney, small intestine, and brain in adjuvant-induced arthritic rats. J Pharm Sci. 103(8):2556–2564.
   PubMed Web of Science ®Google Scholar
• Khachigian LM. 2006. Collagen antibody-induced arthritis. Nat Protoc. 1(5):2512–2516.
   PubMed Web of Science ®Google Scholar
• Kimoto E, Mathialagan S, Tylaska L, Niosi M, Lin J, Carlo AA, Tess DA, Varma MVS. 2018. Organic anion transporter 2-mediated hepatic uptake contributes to the clearance of high-permeability-low-molecular-weight acid and zwitterion drugs: evaluation using 25 drugs. J Pharmacol Exp Ther. 367(2):322–334.
   PubMed Web of Science ®Google Scholar
• Klaunig JE, Goldblatt PJ, Hinton DE, Lipsky MM, Chacko J, Trump BF. 1981. Mouse liver cell culture. I. Hepatocyte isolation. In Vitro. 17(10):913–925.
   PubMedGoogle Scholar
• Kobayashi T, Murasawa A, Komatsu Y, Yokoyama T, Ishida K, Abe A, Yamamoto K, Yoshie H. 2010. Serum cytokine and periodontal profiles in relation to disease activity of rheumatoid arthritis in Japanese adults. J Periodontol. 81(5):650–657.
   PubMed Web of Science ®Google Scholar
• Le Vee M, Lecureur V, Stieger B, Fardel O. 2009. Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6. Drug Metab Dispos. 37(3):685–693.
   PubMed Web of Science ®Google Scholar
• Lee C-M, Pohl J, Morgan ET. 2009. Dual mechanisms of CYP3A protein regulation by proinflammatory cytokine stimulation in primary hepatocyte cultures. Drug Metab Dispos. 37(4):865–872.
   PubMed Web of Science ®Google Scholar
• Li T-T, An J-X, Xu J-Y, Tuo B-G. 2019. Overview of organic anion transporters and organic anion transporter polypeptides and their roles in the liver. World J Clin Cases. 7(23):3915–3933.
   PubMed Web of Science ®Google Scholar
• Lin C-H, Hsu K-W, Chen C-H, Uang Y-S, Lin C-J. 2017. Differential changes in the pharmacokinetics of statins in collagen-induced arthritis rats. Biochem Pharmacol. 142:216–228.
   PubMed Web of Science ®Google Scholar
• Marada VVVR, Flörl S, Kühne A, Müller J, Burckhardt G, Hagos Y. 2015. Interaction of human organic anion transporter 2 (OAT2) and sodium taurocholate cotransporting polypeptide (NTCP) with antineoplastic drugs. Pharmacol Res. 91:78–87.
   PubMed Web of Science ®Google Scholar
• Mayo PR, Skeith K, Russell AS, Jamali F. 2000. Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis. Br J Clin Pharmacol. 50(6):605–613.
   PubMed Web of Science ®Google Scholar
• Ohtsuki S, Schaefer O, Kawakami H, Inoue T, Liehner S, Saito A, Ishiguro N, Kishimoto W, Ludwig-Schwellinger E, Ebner T, et al. 2012. Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities. Drug Metab Dispos. 40(1):83–92.
   PubMed Web of Science ®Google Scholar
• Ono H, Tanaka R, Suzuki Y, Oda A, Ozaki T, Tatsuta R, Maeshima K, Ishii K, Ohno K, Shibata H, et al. 2021. Factors Influencing Plasma Coproporphyrin-I Concentration as Biomarker of OATP1B Activity in Patients With Rheumatoid Arthritis. Clin Pharmacol Ther. 110(4):1096–1105.
   PubMed Web of Science ®Google Scholar
• Pavlova A, Sakurai H, Leclercq B, Beier DR, Yu AS, Nigam SK. 2000. Developmentally regulated expression of organic ion transporters NKT (OAT1), OCT1, NLT (OAT2), and Roct. Am J Physiol Renal Physiol. 278(4):F635–43.
   PubMed Web of Science ®Google Scholar
• Saib S, Delavenne X. 2021. Inflammation induces changes in the functional expression of P-gp, BCRP, and MRP2: An overview of different models and consequences for drug disposition. Pharmaceutics. 13(10):1544.
   PubMed Web of Science ®Google Scholar
• Schmitt C, Kuhn B, Zhang X, Kivitz AJ, Grange S. 2011. Disease-drug-drug interaction involving tocilizumab and simvastatin in patients with rheumatoid arthritis. Clin Pharmacol Ther. 89(5):735–740.
   PubMed Web of Science ®Google Scholar
• Stanke-Labesque F, Gautier-Veyret E, Chhun S, Guilhaumou R, French Society of Pharmacology and Therapeutics 2020. Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment. Pharmacol Ther. 215:107627.
   PubMed Web of Science ®Google Scholar
• Sukhai M, Yong A, Pak A, Piquette-Miller M. 2001. Decreased expression of P-glycoprotein in interleukin-1beta and interleukin-6 treated rat hepatocytes. Inflamm Res. 50(7):362–370.
   PubMed Web of Science ®Google Scholar
• Wang H, Han Q, Chen Y, Hu G, Xing H. 2021. Novel insights into cytochrome P450 enzyme and solute carrier families in cadmium-induced liver injury of pigs. Ecotoxicol Environ Saf. 211:111910.
   PubMed Web of Science ®Google Scholar
• Wollmann BM, Syversen SW, Vistnes M, Lie E, Mehus LL, Molden E. 2018. Associations between cytokine levels and CYP3A4 phenotype in patients with rheumatoid arthritis. Drug Metab Dispos. 46(10):1384–1389.
   PubMed Web of Science ®Google Scholar
• Wu K-C, Lin C-J. 2019. The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: Evidences in inflammatory diseases and age-related disorders. J Food Drug Anal. 27(1):48–59.
   PubMed Web of Science ®Google Scholar
• Yasui Y, Kudo A, Kurosaki M, Matsuda S, Muraoka M, Tamaki N, Suzuki S, Hosokawa T, Ueda K, Matsunaga K, et al. 2014. Reduced organic anion transporter expression is a risk factor for hepatocellular carcinoma in chronic hepatitis C patients: a propensity score matching study. Oncology. 86(1):53–62.
   PubMed Web of Science ®Google Scholar